Source: A Brain-Mind Odyssey, UC Berkeley
Tags: neurotransmitters, acetylcholine, dopamine, norepinephrine, serotonin, monoamines, GPCR, ionotropic, seizures, GABA, cortical homeostasis, locus coeruleus, basal forebrain, ventral tegmentum, substantia nigra
The central nervous system uses a range of neurotransmitter systems, including acetylcholine, dopamine, norepinephrine, and serotonin, each originating from small clusters of cells in the brainstem and projecting widely across the brain. These neuromodulators alter how neural circuits function. The brain also maintains its own homeostasis: a balance of excitatory and inhibitory neurons prevents runaway activity, and when that balance breaks down, the result is seizures.
Acetylcholine (ACh)
A neurotransmitter critical for arousal in the brain. In the ANS, it is released by parasympathetic nerves. In the CNS, it is generated in the basal forebrain nuclei and midbrain pontine nuclei.
Neuromodulators
Substances that change how neural circuits work, rather than directly excite or inhibit a single synapse. Acetylcholine, serotonin, dopamine, and norepinephrine all function as neuromodulators.
Monoamine neurotransmitters
A class of neurotransmitters synthesised through a series of enzymatic steps. The biosynthetic pathway runs: DOPA → dopamine → norepinephrine → epinephrine. Serotonin is also a monoamine but follows a separate pathway. The molecules in this family are structurally similar.
Dopamine
A monoamine neurotransmitter involved in reward circuitry and motor control. Produced in the ventral tegmentum (projects to frontal cortex and nucleus accumbens) and the substantia nigra (projects to basal ganglia).
Norepinephrine
A monoamine neurotransmitter released from the locus coeruleus, which projects throughout the entire brain. In the ANS, it is the sympathetic neurotransmitter that increases heart rate.
Serotonin
A monoamine neurotransmitter produced in the raphe nuclei and sent to various parts of the brain. Involved in mood, arousal, and a wide range of CNS functions.
GPCR (G-protein coupled receptor)
A type of metabotropic receptor. GPCRs respond to glutamate, GABA, acetylcholine, serotonin, adenosine, dopamine, norepinephrine, and many other neurotransmitters. They are key drug targets throughout the brain.
Ionotropic receptor
A receptor that is itself an ion channel. When a neurotransmitter binds, the channel opens directly, producing a fast response.
Cortical neuropil
The dense network of neural processes in the cortex. About 80% of cortical neurons are excitatory, creating a highly recurrent network that is prone to positive feedback.
GABAergic neurons
Inhibitory neurons that release GABA. They make up roughly 20% of cortical neurons but are very active, keeping the excitatory majority in check and preventing runaway activity.
Seizures (epileptic seizures)
Runaway neural activity in the brain caused by positive feedback in excitatory circuits spiralling out of control. Normally prevented by GABAergic inhibition.
Peptide neurotransmitters
Short chains of amino acids that function as neurotransmitters. Examples include endorphins (opioid peptides) and substance P.
Endocannabinoids
A class of neurotransmitter. Lipid-based signalling molecules produced naturally in the brain.
Acetylcholine is released in the brain and is critical for arousal. It is generated in a few sets of nuclei:
Basal forebrain nuclei – a major source of cortical acetylcholine
Midbrain pontine nuclei – contribute to brainstem cholinergic signalling
The raphe nuclei are a separate structure that sends serotonin (not acetylcholine) to parts of the brain. Both systems act as neuromodulators, changing how circuits operate rather than simply switching neurons on or off.
Monoamine neurotransmitters are built through a series of enzymatic steps, with specific enzymes catalysing each conversion:
DOPA → dopamine → norepinephrine → epinephrine
The molecules in this pathway look structurally similar. Serotonin is also a monoamine but is synthesised via a separate pathway from tryptophan.
Dopamine is produced in two main areas:
Ventral tegmentum – neurons here release dopamine to the frontal cortex and nucleus accumbens. This pathway is central to reward circuitry.
Substantia nigra – neurons here release dopamine to the basal ganglia. These are the cells that typically die early in Parkinson's disease, leading to both motor and cognitive impairments.
Locus coeruleus – the primary source of norepinephrine in the brain, projecting throughout the entire brain
A key feature of monoaminergic systems: they emerge from small clusters of cells in the brainstem and innervate the entire brain. This is not point-to-point signalling. These systems broadcast widely, modulating brain-wide activity.
Amino acids: glutamate, GABA, glycine
Made from amino acids (monoamines): serotonin, dopamine, norepinephrine
Other small molecules: acetylcholine, adenosine, ATP
Peptides: endorphins, substance P
Others: endocannabinoids, nitric oxide
GPCR (metabotropic) – respond to glutamate, GABA, acetylcholine, serotonin, adenosine, dopamine, norepinephrine, and others. These are key drug targets throughout the brain.
Ionotropic – ion channels that open directly when a neurotransmitter binds, producing a fast synaptic response.
The cortex is a highly recurrent network, and about 80% of its neurons are excitatory. This architecture is useful for computation but creates a vulnerability: positive feedback can cause an explosive runaway event.
Epileptic seizures are exactly this: runaway neural activity where excitatory circuits spiral out of control.
Under normal conditions, this is prevented by the 20% of cortical neurons that are GABAergic (inhibitory). These neurons are very active and keep excitatory cells in check. When GABAergic inhibition fails or is weakened, seizures can result.
This is another example of the balance principle seen in the ANS: homeostasis depends on opposing forces (excitation and inhibition) staying in equilibrium.
Peptide neurotransmitters are short chains of amino acids, essentially small pieces of proteins. Examples include endorphins (the brain's own opioid peptides) and substance P. Changing neuropeptide signalling can happen through relatively simple molecular modifications.
Monoamine biosynthetic pathway:
DOPA → dopamine → norepinephrine → epinephrine
(Each step is catalysed by a specific enzyme.)
Cortical excitation/inhibition balance:
~80% excitatory neurons + ~20% GABAergic inhibitory neurons = stable cortical activity
If GABAergic inhibition fails → positive feedback → seizure
⚠️ Monoaminergic systems originate from small brainstem clusters but project across the entire brain. They are not point-to-point circuits. This is a commonly tested distinction.
⚠️ Know the dopamine pathways: ventral tegmentum → frontal cortex/nucleus accumbens (reward) and substantia nigra → basal ganglia (motor). Substantia nigra degeneration is the hallmark of Parkinson's disease.
⚠️ GPCRs are the major class of drug target in the brain. Know that they are metabotropic, in contrast to ionotropic receptors (ion channels).
⚠️ The cortex is 80% excitatory, 20% inhibitory (GABAergic). Loss of GABAergic inhibition leads to seizures. This ratio is a frequent exam point.
⚠️ Seizures are caused by positive feedback in excitatory circuits, the same type of feedback that is dangerous in ANS control of blood pressure.
⚠️ Know the five molecular classes of neurotransmitters: amino acids, monoamines, other small molecules, peptides, and others (endocannabinoids, nitric oxide).
Q: Where is acetylcholine generated in the brain, and what is its primary CNS role?
A: In the basal forebrain nuclei and the midbrain pontine nuclei. It is critical for arousal.
Q: What is the biosynthetic pathway for catecholamine neurotransmitters?
A: DOPA → dopamine → norepinephrine → epinephrine. Each step is catalysed by a specific enzyme.
Q: Name the two main brain regions that produce dopamine and their projection targets.
A: The ventral tegmentum projects to the frontal cortex and nucleus accumbens (reward circuitry). The substantia nigra projects to the basal ganglia (motor control). Loss of substantia nigra cells is characteristic of Parkinson's disease.
Q: What is distinctive about the way monoaminergic systems innervate the brain?
A: They originate from small clusters of cells in the brainstem and project broadly across the entire brain, rather than using point-to-point connections. They modulate brain-wide activity.
Q: Why is the cortex vulnerable to seizures, and what normally prevents them?
A: About 80% of cortical neurons are excitatory, creating a highly recurrent network prone to positive feedback. The 20% of neurons that are GABAergic (inhibitory) normally keep excitatory activity in check. When GABAergic inhibition fails, excitatory circuits can spiral out of control, producing seizures.
Q: What are the two main types of neurotransmitter receptors?
A: GPCRs (G-protein coupled receptors), which are metabotropic and are major drug targets, and ionotropic receptors, which are ion channels that open directly when a neurotransmitter binds.
Q: List the five molecular categories of neurotransmitters with an example of each.
A: Amino acids (glutamate, GABA, glycine), monoamines made from amino acids (serotonin, dopamine, norepinephrine), other small molecules (acetylcholine, adenosine, ATP), peptides (endorphins, substance P), and others (endocannabinoids, nitric oxide).
neurotransmitters, acetylcholine, dopamine, norepinephrine, serotonin, epinephrine, monoamine, catecholamine, GPCR, G-protein coupled receptor, metabotropic, ionotropic, basal forebrain, midbrain pontine nuclei, raphe nuclei, ventral tegmentum, substantia nigra, nucleus accumbens, locus coeruleus, basal ganglia, Parkinson's disease, reward circuitry, neuromodulators, GABA, GABAergic, excitatory, inhibitory, cortical neuropil, seizures, epilepsy, positive feedback, peptide neurotransmitters, endorphins, substance P, endocannabinoids, nitric oxide, brain homeostasis